162 related articles for article (PubMed ID: 30095767)
1. Repeat Screening for Syphilis in the Third Trimester of Pregnancy: A Cost-Effectiveness Analysis.
Hersh AR; Megli CJ; Caughey AB
Obstet Gynecol; 2018 Sep; 132(3):699-707. PubMed ID: 30095767
[TBL] [Abstract][Full Text] [Related]
2. Third-Trimester Prenatal Syphilis Screening: A Cost-Effectiveness Analysis.
Albright CM; Emerson JB; Werner EF; Hughes BL
Obstet Gynecol; 2015 Sep; 126(3):479-485. PubMed ID: 26244531
[TBL] [Abstract][Full Text] [Related]
3. Antenatal syphilis screening using point-of-care testing in Sub-Saharan African countries: a cost-effectiveness analysis.
Kuznik A; Lamorde M; Nyabigambo A; Manabe YC
PLoS Med; 2013 Nov; 10(11):e1001545. PubMed ID: 24223524
[TBL] [Abstract][Full Text] [Related]
4. Repeat screening for syphilis in pregnancy as an alternative screening strategy in the UK: a cost-effectiveness analysis.
Huntington S; Weston G; Seedat F; Marshall J; Bailey H; Tebruegge M; Ahmed I; Turner K; Adams E
BMJ Open; 2020 Nov; 10(11):e038505. PubMed ID: 33444184
[TBL] [Abstract][Full Text] [Related]
5. Herpes Simplex Virus Serotyping in Pregnant Women With a History of Genital Herpes and an Outbreak in the Third Trimester of Pregnancy: A Cost-Effectiveness Analysis.
Chatroux IC; Hersh AR; Caughey AB
Obstet Gynecol; 2021 Jan; 137(1):63-71. PubMed ID: 33278294
[TBL] [Abstract][Full Text] [Related]
6. Universal Repeat Screening for Human Immunodeficiency Virus in the Third Trimester of Pregnancy: A Cost-Effectiveness Analysis.
Hawkinson LF; Chaiken SR; Doshi U; Wallace J; Caughey AB
Obstet Gynecol; 2023 Mar; 141(3):535-543. PubMed ID: 36800852
[TBL] [Abstract][Full Text] [Related]
7. Cost and clinical utility of repeated syphilis screening in the third trimester in a high-risk population.
Shiber L; Todia WJ
Am J Obstet Gynecol; 2014 Mar; 210(3):267.e1-5. PubMed ID: 24333235
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of integrated routine offering of prenatal HIV and syphilis screening in China.
Owusu-Edusei K; Tao G; Gift TL; Wang A; Wang L; Tun Y; Wei X; Wang L; Fuller S; Kamb ML; Bulterys M
Sex Transm Dis; 2014 Feb; 41(2):103-10. PubMed ID: 24413489
[TBL] [Abstract][Full Text] [Related]
9. The cost and cost-effectiveness of scaling up screening and treatment of syphilis in pregnancy: a model.
Kahn JG; Jiwani A; Gomez GB; Hawkes SJ; Chesson HW; Broutet N; Kamb ML; Newman LM
PLoS One; 2014; 9(1):e87510. PubMed ID: 24489931
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of HIV and syphilis antenatal screening: a modelling study.
Bristow CC; Larson E; Anderson LJ; Klausner JD
Sex Transm Infect; 2016 Aug; 92(5):340-6. PubMed ID: 26920867
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of rapid syphilis screening in prenatal HIV testing programs in Haiti.
Schackman BR; Neukermans CP; Fontain SN; Nolte C; Joseph P; Pape JW; Fitzgerald DW
PLoS Med; 2007 May; 4(5):e183. PubMed ID: 17535105
[TBL] [Abstract][Full Text] [Related]
12. Using Surveillance Data to Respond to an Outbreak of Congenital Syphilis in Arizona Through Third-Trimester Screening Policies, 2017-2018.
Sykes KJ; Scranton RA; Villarroel L; Anderson BV; Salek S; Stall J
Public Health Rep; 2021; 136(1):61-69. PubMed ID: 33211993
[TBL] [Abstract][Full Text] [Related]
13. Universal Hepatitis B Antibody Screening and Vaccination in Pregnancy: A Cost-Effectiveness Analysis.
Prabhu M; Susich MK; Packer CH; Hersch AR; Riley LE; Caughey AB
Obstet Gynecol; 2022 Mar; 139(3):357-367. PubMed ID: 35115449
[TBL] [Abstract][Full Text] [Related]
14. Hospitalization cost of congenital syphilis diagnosis from insurance claims data in the United States.
Owusu-Edusei K; Introcaso CE; Chesson HW
Sex Transm Dis; 2013 Mar; 40(3):226-9. PubMed ID: 23407468
[TBL] [Abstract][Full Text] [Related]
15. Strategic options for antenatal screening for syphilis in the United Kingdom: a cost effectiveness analysis.
Connor N; Roberts J; Nicoll A
J Med Screen; 2000; 7(1):7-13. PubMed ID: 10807140
[TBL] [Abstract][Full Text] [Related]
16. Modelling the cost-effectiveness of introducing rapid syphilis tests into an antenatal syphilis screening programme in Mwanza, Tanzania.
Vickerman P; Peeling RW; Terris-Prestholt F; Changalucha J; Mabey D; Watson-Jones D; Watts C
Sex Transm Infect; 2006 Dec; 82 Suppl 5(Suppl 5):v38-43. PubMed ID: 17215276
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of a dual non-treponemal/treponemal syphilis point-of-care test to prevent adverse pregnancy outcomes in sub-Saharan Africa.
Owusu-Edusei K; Gift TL; Ballard RC
Sex Transm Dis; 2011 Nov; 38(11):997-1003. PubMed ID: 21992974
[TBL] [Abstract][Full Text] [Related]
18. [Positive results from serologic screening for syphilis in pregnancy in the Amsterdam region, 1991-1995].
Bont J; Cairo I; van Doornum GJ; Coutinho RA; Bleker OP
Ned Tijdschr Geneeskd; 1999 Nov; 143(46):2312-5. PubMed ID: 10589219
[TBL] [Abstract][Full Text] [Related]
19. Cost-benefit analysis of a prenatal preventive programme against congenital syphilis.
Stray-Pedersen B
NIPH Ann; 1980 May; 3(1):57-66. PubMed ID: 6779243
[TBL] [Abstract][Full Text] [Related]
20. Assessing compliance with a county board order for third trimester syphilis screening in Maricopa County, Arizona.
Collier MG; Taylor MM; Winscott MM; Mickey T; England B
Sex Reprod Healthc; 2011 Aug; 2(3):125-8. PubMed ID: 21742292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
